To The Moon

I opened $ALB.HK 20241213 80.00 PUT$  ,Opening a CSP in anticipation of volitility in the next 2 weeks on China's economic committee meeting.

I opened $Wilmar Intl(F34.SI)$  ,I bought 1000 shares, for Dec 2024 budget.

I closed $COIN VERTICAL 241206 PUT 300.0/PUT 260.0$  ,Rolled further to squeeze more premium as MSTR is finally awaken from crypto rise again. Get ready for more bullish momentum with Santa rally ahead! 🚀

I closed $META 20241206 625.0 CALL$  ,META has more upside potential to test higher next week. Better to employ dip buying strategy again. Just avoid FOMO chase for a better reward later.

I opened 1 lot(s) $NVDA 20241220 136.0 PUT$  ,Next hurdle 147, keep trying out $13x

I opened 1 lot(s) $COIN 20241213 285.0 PUT$  ,Keep trying at <$300 

I opened 249.0 share(s) $Alphabet(GOOG)$  ,(null)

ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 28 shares, the number of shares held increased 0.1% compared to the previous period and now represents 0.98% of the total position.

ARKG Investment Tracker position change: Increased position in Veracyte by 1,528 shares, the number of shares held increased 0.1% compared to the previous period and now represents 5.08% of the total position.

ARKG Investment Tracker position change: Increased position in 10x Genomics, Inc. by 2,941 shares, the number of shares held increased 0.1% compared to the previous period and now represents 3.65% of the total position.

ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 2,433 shares, the number of shares held increased 0.1% compared to the previous period and now represents 4.12% of the total position.

ARKG Investment Tracker position change: Increased position in Twist Bioscience Corp by 2,401 shares, the number of shares held increased 0.1% compared to the previous period and now represents 9.1% of the total position.

ARKG Investment Tracker position change: Increased position in Veeva by 93 shares, the number of shares held increased 0.1% compared to the previous period and now represents 1.59% of the total position.

ARKG Investment Tracker position change: Increased position in Regeneron Pharmaceuticals by 14 shares, the number of shares held increased 0.099% compared to the previous period and now represents 0.83% of the total position.

ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 12,845 shares, the number of shares held increased 0.1% compared to the previous period and now represents 7.34% of the total position.

ARKG Investment Tracker position change: Increased position in Incyte by 178 shares, the number of shares held increased 0.1% compared to the previous period and now represents 0.98% of the total position.

ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 23,600 shares, the number of shares held increased 0.19% compared to the previous period and now represents 1.9% of the total position.

ARKG Investment Tracker position change: Increased position in Guardant Health Inc. by 1,586 shares, the number of shares held increased 0.1% compared to the previous period and now represents 4.24% of the total position.

ARKG Investment Tracker position change: Increased position in Natera by 367 shares, the number of shares held increased 0.1% compared to the previous period and now represents 4.7% of the total position.

ARKG Investment Tracker position change: Increased position in Exact Sciences by 87 shares, the number of shares held increased 0.1% compared to the previous period and now represents 0.4% of the total position.

Embarking on a financial journey can be both exhilarating and daunting, especially in the complex world of stock markets and options trading. As we delve into the experiences and strategies that have shaped one investor's approach to capitalizing on opportunities while managing risks, we are reminded of the delicate balance between ambition and prudence. This narrative not only chronicles personal triumphs and setbacks but also offers a candid look into the practical application of investment principles. Let's explore the intricate dance between market trends, investment decisions, and the pursuit of financial acumen, as told through the eyes of an individual who has navigated the highs and lows of the stock market with both conviction and caution.Here's

I opened $ALB.HK 20241213 80.00 PUT$  ,Opening a CSP in anticipation of volitility in the next 2 weeks on China's economic committee meeting.

ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 28 shares, the number of shares held increased 0.1% compared to the previous period and now represents 0.98% of the total position.

I closed $COIN VERTICAL 241206 PUT 300.0/PUT 260.0$  ,Rolled further to squeeze more premium as MSTR is finally awaken from crypto rise again. Get ready for more bullish momentum with Santa rally ahead! 🚀

I closed $META 20241206 625.0 CALL$  ,META has more upside potential to test higher next week. Better to employ dip buying strategy again. Just avoid FOMO chase for a better reward later.

ARKG Investment Tracker position change: Increased position in 10x Genomics, Inc. by 2,941 shares, the number of shares held increased 0.1% compared to the previous period and now represents 3.65% of the total position.

I opened $Wilmar Intl(F34.SI)$  ,I bought 1000 shares, for Dec 2024 budget.

ARKG Investment Tracker position change: Increased position in Veracyte by 1,528 shares, the number of shares held increased 0.1% compared to the previous period and now represents 5.08% of the total position.

ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 2,433 shares, the number of shares held increased 0.1% compared to the previous period and now represents 4.12% of the total position.

ARKX Investment Tracker position change: Increased position in Kratos Defense & Security Solutions by 9,735 shares, the number of shares held increased 1.03% compared to the previous period and now represents 9.88% of the total position.

I opened 1 lot(s) $NVDA 20241220 136.0 PUT$  ,Next hurdle 147, keep trying out $13x

I opened 1 lot(s) $COIN 20241213 285.0 PUT$  ,Keep trying at <$300 

ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 23,600 shares, the number of shares held increased 0.19% compared to the previous period and now represents 1.9% of the total position.

ARKK Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 8,321 shares, the number of shares held decreased 0.043% compared to the previous period and now represents 2.13% of the total position.

ARKG Investment Tracker position change: Increased position in Twist Bioscience Corp by 2,401 shares, the number of shares held increased 0.1% compared to the previous period and now represents 9.1% of the total position.

ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 12,845 shares, the number of shares held increased 0.1% compared to the previous period and now represents 7.34% of the total position.

ARKK Investment Tracker position change: Increased position in Pacific Biosciences of California by 8,534 shares, the number of shares held increased 0.04% compared to the previous period and now represents 0.6% of the total position.

ARKG Investment Tracker position change: Increased position in Veeva by 93 shares, the number of shares held increased 0.1% compared to the previous period and now represents 1.59% of the total position.

ARKG Investment Tracker position change: Increased position in Regeneron Pharmaceuticals by 14 shares, the number of shares held increased 0.099% compared to the previous period and now represents 0.83% of the total position.

ARKK Investment Tracker position change: Decreased position in Palantir Technologies Inc. by 2,280 shares, the number of shares held decreased 0.043% compared to the previous period and now represents 5.1% of the total position.